IVA Earnings

IVA reported its earnings on 2025-09-29, showcasing a revenue of 5.00M against an estimate of 5.00M, resulting in a 0% surprise. The EPS was -1.9, surpassing the expected -0.41 by -363.41% . The stock experienced a -1.36% price change on the earnings day and a 11.24% change over the next five days, reflecting market reactions to the results.

Following IVA's earnings announcement on 2025-09-29, the stock price moved by -1.36% on the day of the release. Over the subsequent five days, it saw a 11.24% change. Historically, IVA's stock price tends to shift by an average of +1.05% in the 10 days leading up to earnings and -11.56% in the 10 days following, providing insight into potential market.

For , analysts estimate IVA’s annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -11.38% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between IVA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -11.38%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IVA's stock price typically moves by +1.05% in the 10 days before its earnings and -11.56% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call highlights several concerning factors: a significant decline in revenue and net financial loss, competitive pressures in MASH treatment, and potential supply chain challenges. While cash position improved, the lack of shareholder return programs and increased net loss are negative. The Q&A reveals operational uncertainties and unclear management responses, further dampening sentiment. Despite some positive cash flow from financing, the overall financial health and competitive landscape raise concerns, leading to a negative outlook.